Designing Bifunctional NOP Receptor-Mu-Opioid Receptor Ligands from NOP-Receptor Selective Scaffolds. Part II

Citation

Blair Journigan, V., Polgar, W. E., Khroyan, T. V., & Zaveri, N. T. (2014). Designing bifunctional NOP receptor-mu opioid receptor ligands from NOP-receptor selective scaffolds. Part II. Bioorganic & Medicinal Chemistry, 22(8), 2508-2516. doi: 10.1016/j.bmc.2014.02.047

Abstract

The nociceptin opioid receptor (NOP) and its endogenous peptide ligand nociceptin/orphanin FQ have been shown to modulate the pharmacological effects of the classical opioid receptor system. Suppression of opioid-induced reward associated with mu-opioid receptor (MOP)-mediated analgesia, without decreasing anti-nociceptive efficacy, can potentially be achieved with NOP agonists having bifunctional agonist activity at MOP, to afford ‘non-addicting’ analgesics. In Part II of this series, we describe a continuing structure–activity relationship (SAR) study of the NOP-selective piperidin-4-yl-1,3-dihydroindol-2-one scaffold, to obtain bifunctional activity at MOP, and a suitable ratio of NOP/MOP agonist activity that produces a non-addicting analgesic profile. The SAR reported here is focused on the influence of various piperidine nitrogen aromatic substituents on the ratio of binding affinity and intrinsic activity at both the NOP and MOP receptors.


Read more from SRI

  • An arid, rural Nevada landscape

    Can AI help us find valuable minerals?

    SRI’s machine learning-based geospatial analytics platform, already adopted by the USGS, is poised to make waves in the mining industry.

  • Two students in a computer lab

    Building a lab-to-market pipeline for education

    The SRI-led LEARN Network demonstrates how we can get the best evidence-based educational programs to classrooms and students.

  • Code reflected in a man's eyeglasses

    LLM risks from A to Z

    A new paper from SRI and Brazil’s Instituto Eldorado delivers a comprehensive update on the security risks to large language models.